COMPANY PROFILE

Xcellerex

Explore full profile

Single-use biomanufacturing platform for producing therapeutic proteins

Marlborough, United KingdomFounded 2012Biotech & Life Sciences

Valuation $100–250M Last recorded · 2007

Headcount 5–10k Current team size

Total funding $10–50M Disclosed equity funding

At a glance

Status: Acquired
Founded: 2012
Headquarters: Marlborough, United Kingdom
Employees: 6,660
Open positions: None listed
Dealroom signal: 23.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Testing, Biotechnology, DNA, Genetics and genomics, Bioreactors, Genome Engineering
Technology: Big Data, Deep Tech, Computer Vision, Recognition Technology
Business model: Manufacturing
Client focus: b2b
Links: Website X

Founder mafia, market maps, research and news connected to this company by Dealroom

7 recorded events

Company financing events and reported valuations.

Xcellerex website traffic

Latest recorded traffic for Xcellerex is 0 monthly website visits. Xcellerex's team grew 0% over the past year.

Latest monthly visits0 1-year team growth0%

Monthly website visitsJan 2017–May 2020

Summary metrics are public; monthly history is available with a demoCompare with peers →

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CECellartisDevelops human embryonic stem cells and technology for drug discovery research, toxicity testing and regenerative medicine	Göteborgs Stad, Sweden	Acquired	—	$8.8M	$35M
ANAnnoroadA leading developer and marketer on genomic innovation technologies for research and clinical market	Dongcheng District, China	Operational
MUMultiplicom#Multiplicom is the leading Belgian biotech company that develops, manufactures and commercializes molecular diagnostic tests that enable personalized medicine	Antwerp, Belgium	Acquired
DLDante LabsDante Labs is transforming genetics	New York City, United States	Operational
HEHelixThe leading population genomics company working at the intersection of clinical care, research, and genomics	San Mateo, United States	Operational
BGBlueprint GeneticsUses Next Generation Sequencing (NGS) to perform diagnostics on genetic diseases	Espoo, Finland	Operational
PGProbably GeneticProbably Genetic helps rare genetic disease patients get diagnosed	San Francisco, United States	Operational
FIFitgenesAustralian organization that delivers personalized, genome-based health and wellness programs	Brisbane, Australia	Operational